• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCR5构象是动态的,并受定位、运输和G蛋白结合的调节。

CCR5 conformations are dynamic and modulated by localization, trafficking and G protein association.

作者信息

Flegler Ayanna J, Cianci Gianguido C, Hope Thomas J

机构信息

Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.

出版信息

PLoS One. 2014 Feb 28;9(2):e89056. doi: 10.1371/journal.pone.0089056. eCollection 2014.

DOI:10.1371/journal.pone.0089056
PMID:24586501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3938464/
Abstract

CCR5 acts as the principal coreceptor during HIV-1 transmission and early stages of infection. Efficient HIV-1 entry requires a series of processes, many dependent on the conformational state of both viral envelope protein and cellular receptor. Monoclonal antibodies (MAbs) are able to identify different CCR5 conformations, allowing for their use as probes to distinguish CCR5 populations. Not all CCR5 MAbs are able to reduce HIV-1 infection, suggesting the use of select CCR5 populations for entry. In the U87.CD4.CCR5-GFP cell line, we used such HIV-1-restricting MAbs to probe the relation between localization, trafficking and G protein association for individual CCR5 conformations. We find that CCR5 conformations not only exhibit different localization and abundance patterns throughout the cell, but that they also display distinct sensitivities to endocytosis inhibition. Using chemokine analogs that vary in their HIV-1 inhibitory mechanisms, we also illustrate that responses to ligand engagement are conformation-specific. Additionally, we provide supporting evidence for the select sensitivity of conformations to G protein association. Characterizing the link between the function and dynamics of CCR5 populations has implications for understanding their selective targeting by HIV-1 and for the development of inhibitors that will block CCR5 utilization by the virus.

摘要

CCR5在HIV-1传播和感染早期阶段作为主要的共受体发挥作用。高效的HIV-1进入需要一系列过程,其中许多过程依赖于病毒包膜蛋白和细胞受体的构象状态。单克隆抗体(MAb)能够识别不同的CCR5构象,使其可用作区分CCR5群体的探针。并非所有CCR5单克隆抗体都能减少HIV-1感染,这表明可利用特定的CCR5群体来实现病毒进入。在U87.CD4.CCR5-GFP细胞系中,我们使用这类限制HIV-1的单克隆抗体来探究单个CCR5构象的定位、运输和G蛋白结合之间的关系。我们发现,CCR5构象不仅在整个细胞中呈现出不同的定位和丰度模式,而且它们对胞吞作用抑制也表现出不同的敏感性。使用HIV-1抑制机制不同的趋化因子类似物,我们还表明对配体结合的反应具有构象特异性。此外,我们为构象对G蛋白结合的选择性敏感性提供了支持证据。表征CCR5群体的功能与动态之间的联系,对于理解HIV-1对它们的选择性靶向以及开发能阻断病毒利用CCR5的抑制剂具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/a71702f203c1/pone.0089056.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/03f8dad8a883/pone.0089056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/dcd1caa1b041/pone.0089056.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/218c67ec9dfa/pone.0089056.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/d4966cf504ab/pone.0089056.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/5c87b488b0be/pone.0089056.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/a71702f203c1/pone.0089056.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/03f8dad8a883/pone.0089056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/dcd1caa1b041/pone.0089056.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/218c67ec9dfa/pone.0089056.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/d4966cf504ab/pone.0089056.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/5c87b488b0be/pone.0089056.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23cc/3938464/a71702f203c1/pone.0089056.g006.jpg

相似文献

1
CCR5 conformations are dynamic and modulated by localization, trafficking and G protein association.CCR5构象是动态的,并受定位、运输和G蛋白结合的调节。
PLoS One. 2014 Feb 28;9(2):e89056. doi: 10.1371/journal.pone.0089056. eCollection 2014.
2
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.HIV-1 利用 CCR5 构象异质性来逃避趋化因子的抑制。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9475-80. doi: 10.1073/pnas.1222205110. Epub 2013 May 21.
3
CCR5 structural plasticity shapes HIV-1 phenotypic properties.CCR5 结构可塑性塑造了 HIV-1 的表型特征。
PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.
4
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.小分子 CCR5 配体抑制 HIV-1 感染的机制的新见解。
J Biol Chem. 2011 Feb 18;286(7):4978-90. doi: 10.1074/jbc.M110.168955. Epub 2010 Nov 30.
5
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.CCR5单克隆抗体对1型人类免疫缺陷病毒融合、gp120结合及CC趋化因子活性的差异性抑制作用
J Virol. 1999 May;73(5):4145-55. doi: 10.1128/JVI.73.5.4145-4155.1999.
6
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies.鉴定允许 HIV-1 进入和产生感染的 CCR5 核心受体群体:对体内研究的意义。
J Transl Med. 2022 Jan 24;20(1):39. doi: 10.1186/s12967-022-03243-8.
7
Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.酪氨酸硫酸化肽可逆且高效地激活 HIV-1 细胞进入,揭示了内吞进入和抑制剂作用机制。
J Virol. 2014 Apr;88(8):4304-18. doi: 10.1128/JVI.03447-13. Epub 2014 Jan 29.
8
Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.CD4模拟化合物对原代人免疫缺陷病毒包膜糖蛋白三聚体的激活与失活作用
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01880-16. Print 2017 Feb 1.
9
A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.一种双模拟肽通过桥接 gp120 的 CD4 和辅助受体结合位点,有效地中和 HIV-1。
J Virol. 2014 Mar;88(6):3353-8. doi: 10.1128/JVI.03800-13. Epub 2014 Jan 3.
10
Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion.组成性激活的 CCR5 趋化因子受体在介导 HIV 包膜依赖性融合方面存在差异。
PLoS One. 2013;8(1):e54532. doi: 10.1371/journal.pone.0054532. Epub 2013 Jan 23.

引用本文的文献

1
Inhibition of inflammatory cell infiltration by antagonistic peptides that specifically bind to CCR5 via regulation of the NF-κB signaling pathway in rats with colitis.通过调节结肠炎大鼠的NF-κB信号通路,特异性结合CCR5的拮抗肽对炎性细胞浸润的抑制作用。
Arch Med Sci. 2021 May 7;20(6):2022-2033. doi: 10.5114/aoms/127587. eCollection 2024.
2
New insight into a simple high-yielding method for the production of fully folded and functional recombinant human CCL5.对一种简单、高产的生产完全折叠和功能正常的重组人 CCL5 的方法有了新的认识。
Sci Rep. 2024 Oct 15;14(1):24188. doi: 10.1038/s41598-024-75327-y.
3
The chemokine receptor CCR5: multi-faceted hook for HIV-1.

本文引用的文献

1
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.CCR5 趋化因子受体-人类免疫缺陷病毒进入抑制剂马拉维若复合物的结构。
Science. 2013 Sep 20;341(6152):1387-90. doi: 10.1126/science.1241475. Epub 2013 Sep 12.
2
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.HIV-1 利用 CCR5 构象异质性来逃避趋化因子的抑制。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9475-80. doi: 10.1073/pnas.1222205110. Epub 2013 May 21.
3
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants.
趋化因子受体 CCR5:HIV-1 的多面钩。
Retrovirology. 2024 Jan 23;21(1):2. doi: 10.1186/s12977-024-00634-1.
4
Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions.芳基硫酸酯酶和神经氨酸酶通过去除关键静电相互作用来调节趋化因子与 CCR5 的结合。
Sci Rep. 2024 Jan 2;14(1):292. doi: 10.1038/s41598-023-50944-1.
5
CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.CCR5 作为人类免疫缺陷病毒和猴免疫缺陷病毒的核心受体:一种典型的爱恨情仇关系。
Front Immunol. 2022 Jan 27;13:835994. doi: 10.3389/fimmu.2022.835994. eCollection 2022.
6
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies.鉴定允许 HIV-1 进入和产生感染的 CCR5 核心受体群体:对体内研究的意义。
J Transl Med. 2022 Jan 24;20(1):39. doi: 10.1186/s12967-022-03243-8.
7
Co-receptor signaling in the pathogenesis of neuroHIV.共受体信号在神经 HIV 发病机制中的作用。
Retrovirology. 2021 Aug 24;18(1):24. doi: 10.1186/s12977-021-00569-x.
8
Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor.HIV-1 gp120 识别 CCR5 的建模:病毒蛋白如何利用共受体的构象可塑性。
Viruses. 2021 Jul 18;13(7):1395. doi: 10.3390/v13071395.
9
Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.物质滥用诱导的多巴胺水平改变马拉维若的疗效和髓样细胞上 CCR5 构象的表达:对神经 HIV 的影响。
Front Immunol. 2021 May 19;12:663061. doi: 10.3389/fimmu.2021.663061. eCollection 2021.
10
A biophysical perspective on receptor-mediated virus entry with a focus on HIV.从生物物理角度看受体介导的病毒进入,重点是 HIV。
Biochim Biophys Acta Biomembr. 2020 Jun 1;1862(6):183158. doi: 10.1016/j.bbamem.2019.183158. Epub 2019 Dec 19.
G 蛋白偶联和非偶联 CCR5 受体在 CCR5 抑制剂耐药和敏感的人类免疫缺陷病毒 1 型变异体中的作用。
J Virol. 2013 Jun;87(12):6569-81. doi: 10.1128/JVI.00099-13. Epub 2013 Mar 6.
4
Several commercially available anti-CCR5 monoclonal antibodies lack specificity and should be used with caution.几种市售的抗CCR5单克隆抗体缺乏特异性,应谨慎使用。
Hybridoma (Larchmt). 2012 Feb;31(1):7-19. doi: 10.1089/hyb.2010.0092.
5
Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers.G(q)- 偶联受体和 G(q) 异源三聚体的无活性状态预组装。
Nat Chem Biol. 2011 Aug 28;7(10):740-7. doi: 10.1038/nchembio.642.
6
Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).马拉维若与 CC 趋化因子受体 5(CCR5)结合的变构模型。
J Biol Chem. 2011 Sep 23;286(38):33409-21. doi: 10.1074/jbc.M111.279596. Epub 2011 Jul 20.
7
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.细胞表面的多种 CCR5 构象被对 CCR5 抑制剂有耐药性或敏感性的人类免疫缺陷病毒不同地利用。
J Virol. 2011 Aug;85(16):8227-40. doi: 10.1128/JVI.00767-11. Epub 2011 Jun 15.
8
CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.CC 趋化因子受体 5(CCR5)脱敏:循环受体在反式高尔基网络中积累。
J Biol Chem. 2010 Dec 31;285(53):41772-80. doi: 10.1074/jbc.M110.153460. Epub 2010 Nov 1.
9
A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.一种定量亲和分析系统,可揭示人类免疫缺陷病毒1型和猿猴免疫缺陷病毒毒株之间不同的CD4/CCR5使用模式。
J Virol. 2009 Nov;83(21):11016-26. doi: 10.1128/JVI.01242-09. Epub 2009 Aug 19.
10
The structure and function of G-protein-coupled receptors.G蛋白偶联受体的结构与功能。
Nature. 2009 May 21;459(7245):356-63. doi: 10.1038/nature08144.